Last update : 09/05/2017 | Version : 2 | ID : 177
General | |
Identification | |
Detailed name | Cohort study on management and outcome of patients with chronic Hepatitis C treated with PEG-IFN-alpha2a in combinaison with ribavirin in hospital-based or private office-based |
Sign or acronym | HEPATYS |
General Aspects | |
Medical area |
Gastroenterology et hepatology |
Keywords | chronic hepatitis C, Pegasys |
Scientific investigator(s) (Contact) | |
Name of the director | Pinta |
Surname | Alexandrina |
Phone | +33 (0)1 46 40 43 76 |
alexandrina.pinta@roche.com | |
Unit | ROCHE |
Collaborations | |
Funding | |
Funding status |
Private |
Details | Roche |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | ROCHE |
Organisation status |
Private |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Longitudinal study (except cohorts) |
Database recruitment is carried out by an intermediary |
A selection of health care professionals A selection of health institutions and services |
Database recruitment is is made on the basis of: |
Medication(s) taken |
Database recruitment is carried out as part of an interventional study |
No |
Database objective | |
Main objective | Describe the management and outcome of patients with chronic Hepatitis C treated with PEG-IFN-alpha2a in combinaison with ribavirin in hospital-based or private office-based |
Inclusion criteria |
Patients suffering from chronic hepatitis C for whom a treatment via Pagasys was decided and then initiated, followed in a hospital and general environment
Patients who have been informed of the study orally and in writing |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) |
Population covered |
Sick population |
Gender |
Male Woman |
Geography area |
National |
Detail of the geography area | France |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2003 |
Date of last collection (YYYY or MM/YYYY) | 2006 |
Size of the database | |
Size of the database (number of individuals) |
[1000-10 000[ individuals |
Details of the number of individuals | 2155 |
Data | |
Database activity |
Data collection completed |
Type of data collected |
Clinical data Biological data |
Clinical data (detail) |
Direct physical measures |
Biological data (detail) | HCV viral load, Hb, Platelets, Leukocytes, creatinine |
Presence of a biobank |
No |
Health parameters studied |
Health event/morbidity Health event/mortality Health care consumption and services Quality of life/health perception |
Care consumption (detail) |
Hospitalization Medical/paramedical consultation Medicines consumption |
Procedures | |
Participant monitoring |
Yes |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Link to the document | http://www.ncbi.nlm.nih.gov/pubmed/?term=Pinta+A[author]+AND+hepatys |
Description | List of publications in Pubmed |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | Oral and posted communication at the hepatology congress (AFEF (French Association for the study of the liver), AASLD (American Association for the Study of Liver Diseases), JFHOD (French-Speaking Days on Hepato-Gastroenterology and Digestive Oncology)), infectiology (RICAI (Interdisciplinary Meeting on Anti-Infective Chemotherapy)), pharmaco-economics, pharmaco-epidemiology |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05